Bridgeway Capital Management’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,378
| Closed | -$429K | – | 1199 |
|
|
2025
Q1 | $429K | Sell |
25,378
-72,341
| -74% | -$1.22M | 0.01% | 771 |
|
|
2024
Q4 | $1.8M | Sell |
97,719
-20,391
| -17% | -$377K | 0.04% | 543 |
|
|
2024
Q3 | $2.57M | Sell |
118,110
-5,444
| -4% | -$118K | 0.06% | 463 |
|
|
2024
Q2 | $2.42M | Sell |
123,554
-38,321
| -24% | -$752K | 0.06% | 451 |
|
|
2024
Q1 | $3.51M | Buy |
161,875
+8,225
| +5% | +$178K | 0.07% | 398 |
|
|
2023
Q4 | $4.44M | Sell |
153,650
-40,976
| -21% | -$1.18M | 0.1% | 340 |
|
|
2023
Q3 | $5.2M | Buy |
194,626
+7,426
| +4% | +$199K | 0.13% | 266 |
|
|
2023
Q2 | $6.93M | Buy |
187,200
+16,975
| +10% | +$629K | 0.17% | 189 |
|
|
2023
Q1 | $5.31M | Sell |
170,225
-39,075
| -19% | -$1.22M | 0.14% | 235 |
|
|
2022
Q4 | $6.23M | Buy |
209,300
+25,000
| +14% | +$745K | 0.16% | 204 |
|
|
2022
Q3 | $7.03M | Buy |
184,300
+25,000
| +16% | +$953K | 0.19% | 167 |
|
|
2022
Q2 | $8.69M | Buy |
+159,300
| New | +$8.69M | 0.2% | 160 |
|
|
2020
Q1 | – | Sell |
-78,100
| Closed | -$1.01M | – | 1312 |
|
|
2019
Q4 | $1.01M | Hold |
78,100
| – | – | 0.01% | 736 |
|
|
2019
Q3 | $811K | Hold |
78,100
| – | – | 0.01% | 785 |
|
|
2019
Q2 | $522K | Hold |
78,100
| – | – | 0.01% | 965 |
|
|
2019
Q1 | $465K | Hold |
78,100
| – | – | 0.01% | 1043 |
|
|
2018
Q4 | $248K | Hold |
78,100
| – | – | ﹤0.01% | 1179 |
|
|
2018
Q3 | $307K | Hold |
78,100
| – | – | ﹤0.01% | 1251 |
|
|
2018
Q2 | $323K | Hold |
78,100
| – | – | ﹤0.01% | 1236 |
|
|
2018
Q1 | $311K | Hold |
78,100
| – | – | ﹤0.01% | 1195 |
|
|
2017
Q4 | $342K | Hold |
78,100
| – | – | ﹤0.01% | 1185 |
|
|
2017
Q3 | $369K | Buy |
+78,100
| New | +$369K | ﹤0.01% | 1166 |
|